TILs
TILs
Breakthrough Cancer Treatment Targets Solid Tumors
BIOT
📰 FDA approved first cancer therapy targeting solid tumors using tumor-infiltrating lymphocytes (TILs). Exciting potential for cancer treatment! 👩⚕️🦠🔍
most recent
Process development
Concordia’s $5M Boost for Eco-Friendly Innovation!
Process development
Revolutionary Raman Spectroscopy Calibration Without Bioreactors!
